Novozymes A/S B buy RudolfL
Start price
11.09.20
/
50%
€55.52
Target price
04.11.21
€63.00
Performance (%)
18.70%
End price
05.11.21
€65.90
Summary
This prediction ended on 05.11.21 with a price of €65.90. The prediction had a final performance of 18.70%. A total of €0.71 was paid as dividends for this prediction. RudolfL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novozymes A/S B | 1.205% | 1.205% | 0.351% | 30.783% |
| iShares Core DAX® | 2,57 % | 3,50 % | 8,41 % | 62,27 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % | 28,38 % | 85,45 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % | 52,92 % | 76,58 % |
| iShares S&P 500 | 3,25 % | 2,08 % | 24,37 % | 68,71 % |
According to RudolfL what are the pros and cons of Novozymes A/S B for the foreseeable future?
Pros
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
ROE higher than 15% per year
Cons
Revenue decline/stagnation expected
Comments by RudolfL for this prediction
In the thread Novozymes A/s Nam. B diskutieren
In the thread Trading Novozymes A/s Nam. B
Die von RudolfL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by RudolfL for Novozymes A/S B
Novozymes A/S B
Start price
Target price
Perf. (%)
€46.87
26.01.20
26.01.20
€53.00
13.08.20
13.08.20
5.33%
13.08.20
13.08.20
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected
